Hopfner Robert Lorne — SEC insider filings

SEC reporting owner CIK 1551966. 29 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2021-01-08 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vaxcyte, Inc. (PCVX)Director9—40 legs · 817,549 sh · $22,042,0241
Inozyme Pharma, Inc. (INZY)Director108 legs · 2,903,697 sh · $13,203,084—6
Rallybio Corp (RLYB)Director81 leg · 576,923 sh · $7,499,999—15
Evommune, Inc. (EVMN)Director, 10% owner21 leg · 1,000 sh · $17,350—14

Insider filings — Hopfner Robert Lorne

FiledFormIssuerReported transactionsSource
2026-10-144Rallybio Corp (RLYB)Option exercise (M): 9,196 @ $7.60 · Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 9,196 (derivative) @ $0.56 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2025-12-224Evommune, Inc. (EVMN)Purchase (P): 1,000 @ $17.35EDGAR
2025-11-124Evommune, Inc. (EVMN)Conversion (C): 3,026 · Conversion (C): 1,441,032 · Conversion (C): 1,632,441 · Conversion (C): 294,502 · Conversion (C): 25,790 (derivative) · Conversion (C): 7,145,647 (derivative) · +8 moreEDGAR
2025-07-034Inozyme Pharma, Inc. (INZY)Code (U): 2,923,110 @ $4 · Code (U): 1,571,741 @ $4EDGAR
2025-05-154Rallybio Corp (RLYB)Grant/award (A): 28,500 (derivative) @ $0EDGAR
2025-01-064Rallybio Corp (RLYB)Grant/award (A): 73,571 (derivative) @ $0.70EDGAR
2024-06-204Inozyme Pharma, Inc. (INZY)Grant/award (A): 28,000 (derivative) @ $0EDGAR
2024-05-174Rallybio Corp (RLYB)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2023-08-034Inozyme Pharma, Inc. (INZY)Purchase (P): 119,048 @ $4.80 · Purchase (P): 714,285 @ $4.80EDGAR
2023-06-154Inozyme Pharma, Inc. (INZY)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2023-05-194Rallybio Corp (RLYB)Grant/award (A): 15,490 (derivative) @ $0EDGAR
2023-05-154Inozyme Pharma, Inc. (INZY)Purchase (P): 219,230 @ $6.48 · Purchase (P): 228,702 @ $6.25EDGAR
2023-03-304Inozyme Pharma, Inc. (INZY)Purchase (P): 344,592 @ $4.54EDGAR
2023-03-294Inozyme Pharma, Inc. (INZY)Purchase (P): 51,074 @ $3.70 · Purchase (P): 156,766 @ $4.16EDGAR
2022-06-144Inozyme Pharma, Inc. (INZY)Grant/award (A): 9,367 (derivative) @ $0EDGAR
2022-05-264Rallybio Corp (RLYB)Grant/award (A): 13,440 (derivative) @ $0EDGAR
2022-04-204Inozyme Pharma, Inc. (INZY)Purchase (P): 1,070,000 @ $3.69EDGAR
2022-01-054Rallybio Corp (RLYB)Grant/award (A): 6,242 (derivative) @ $0EDGAR
2021-08-044Rallybio Corp (RLYB)Other (J): 1,694,388 · Purchase (P): 576,923 @ $13 · Other (J): 10,789,193 (derivative) · Grant/award (A): 13,440 (derivative) @ $0EDGAR
2021-06-244Inozyme Pharma, Inc. (INZY)Grant/award (A): 9,367 (derivative) @ $0EDGAR
2021-06-034Vaxcyte, Inc. (PCVX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-02-104Vaxcyte, Inc. (PCVX)Sale (S): 50,874 @ $25.64 · Sale (S): 28,922 @ $26.06 · Sale (S): 38,248 @ $27.12 · Sale (S): 88,756 @ $28.07 · Sale (S): 93,740 @ $28.75 · Sale (S): 37,271 @ $25.75 · +3 moreEDGAR
2021-02-044Vaxcyte, Inc. (PCVX)Sale (S): 14,234 @ $25.13 · Sale (S): 2,768 @ $25.06EDGAR
2021-02-024Vaxcyte, Inc. (PCVX)Sale (S): 2,000 @ $25.07EDGAR
2021-01-274Vaxcyte, Inc. (PCVX)Sale (S): 19,511 @ $25.61 · Sale (S): 15,461 @ $26.07 · Sale (S): 16,769 @ $25.23 · Sale (S): 1,373 @ $26.13 · Sale (S): 2,140 @ $25.30EDGAR
2021-01-224Vaxcyte, Inc. (PCVX)Sale (S): 19,046 @ $25.35 · Sale (S): 100 @ $25.11 · Sale (S): 11,383 @ $25.16EDGAR
2021-01-194Vaxcyte, Inc. (PCVX)Sale (S): 14,918 @ $25.88 · Sale (S): 22,869 @ $25.74 · Sale (S): 3,808 @ $26.05 · Sale (S): 42,516 @ $25.55 · Sale (S): 7,000 @ $26.05EDGAR
2021-01-134Vaxcyte, Inc. (PCVX)Sale (S): 12,480 @ $25.42 · Sale (S): 24,980 @ $26.69 · Sale (S): 12,206 @ $27.02 · Sale (S): 17,666 @ $26.35 · Sale (S): 901 @ $27.05 · Sale (S): 26,010 @ $25.90 · +1 moreEDGAR
2021-01-084Vaxcyte, Inc. (PCVX)Sale (S): 34,913 @ $29.24 · Sale (S): 22,507 @ $29.99 · Sale (S): 24,524 @ $27.75 · Sale (S): 22,587 @ $28.80 · Sale (S): 469 @ $29.51 · Sale (S): 31,468 @ $26.43 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1551966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs